A Stool DNA-Based SDC2 Methylation Test for the Early Detection of Colorectal Cancer in an Asymptomatic, High-Risk Population: A Multicenter Prospective Randomized Trial.
Chang Woo KimHyunjin KimHyoung Rae KimDaeyoun David WonWoo Jung NamByung Soh MinTae Jeong OhSungwhan AnSuk-Hwan LeePublished in: The American journal of gastroenterology (2024)
The stool DNA-based SDC2 methylation test attained a high sensitivity for CRC detection in an asymptomatic high-risk population. Further large-scale clinical studies are required to validate the clinical utility of this test as a population-based CRC screening tool.